Mira Pharmaceuticals (MIRA) Other Accumulated Expenses (2022 - 2025)

Mira Pharmaceuticals has reported Other Accumulated Expenses for 3 years, with the latest figure at $572865.0 in Q4 2025.

• Quarterly Other Accumulated Expenses changed N/A year-over-year to $572865.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $572865.0 (changed N/A YoY) and the FY2025 annual result came in at $572865.0, changed N/A from the prior year.
• Other Accumulated Expenses improved to $572865.0 in Q4 2025 per MIRA's latest filing, from $14592.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $572865.0 in Q4 2025 and troughed at $14592.0 in Q3 2023.
• A 3-year average of $203330.3 and a median of $22534.0 in 2022 frame the typical range for Other Accumulated Expenses.